Article info
PDFClinical science
Three-month outcome of ziv-aflibercept for exudative age-related macular degeneration
- Correspondence to Dr Jay Chhablani, Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Hyderabad 500034, Andhra Pradesh, India; jay.chhablani{at}gmail.com
Citation
Three-month outcome of ziv-aflibercept for exudative age-related macular degeneration
Publication history
- Received December 29, 2015
- Revised February 15, 2016
- Accepted March 5, 2016
- First published March 30, 2016.
Online issue publication
February 19, 2018
Article Versions
- Previous version (19 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/